Expression of Β-Catenin and WT1 in Uterine Mesenchymal Tumors and Their Clinical Significance

廖晓耘,王颖,杜晓媛,张银丽,沈丹华

DOI: https://doi.org/10.3969/j.issn.1002-266x.2010.08.008

2010-01-01

Abstract:Objective To detect the expression of β-catenin and WT1 in uterine mesenchymal tumors and to explore their clinical significance.Methods Immunostaining of β-catenin and WT1 by EnVision method was carried out in 25 cases of endometrial stromal sarcomas,9 leiomyosarcomas,16 uterine leiomyoma(including 7 highly cellular uterine leiomyomas),as well as 8 cases of normal uterine myometrium and 6 cases of normal endometrium.Results Nuclear expression of β-catenin was observed in 80%(20/25) of endometrial stromal sarcomas while only 22.2%(2/9) of leiomyosarcoma and 6.25%(1/16) leiomyoma had β-catenin nuclear expression(P=0.004,P0.001).No nuclear β-catenin expression was found in smooth muscle cells of normal uterine myometrium.Positive WT1 expression was detected in normal endometrial stroma cells,smooth muscle cells of normal uterine myometria and leiomyomas whereas the expression intensity of WT1 was significantly reduced in uterine leiomyosarcomas and endometrial stromal sarcomas(P=0.007,P=0.002).Conclusions Expression of β-catenin and WT1 might play a role in the tumorigenesis of uterine mesenchymal sarcomas,particularly in that of endometrial stromal sarcomas.Nuclear expression of β-catenin might also be helpful in differentiating endometrial stromal sarcomas from uterine smooth muscle tumors.